The tool can help users evaluate whether AI initiatives are incurring costs without corresponding business value or usage, an ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...